Geode Capital Management LLC lifted its position in Vigil Neuroscience, Inc. (NASDAQ:VIGL – Free Report) by 41.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 226,083 shares of the ...

Geode Capital Management LLC grew its holdings in shares of Alto Neuroscience, Inc. (NYSE:ANRO – Free Report) by 148.7% in ...

A study of over 1,000 employees found that sedentary jobs and nontraditional work schedules significantly increase the risk ...

Iluzanebart is under clinical development by Vigil Neuroscience and currently in Phase I for Unspecified Neurologic Disorders.

Aspen Neuroscience, Inc. has advanced its plans for automating production of ANPD001, including a capacity expansion for autologous manufacturing at its San Diego -based GMP facility.

The stock market saw something incredible in 2024, with the “Magnificent 7” tech giants leading the charge and driving a huge ...

You can break the stock market into different components, such as investing styles. These are growth and value stocks. Start ...

Neuroprosthetics research has entered a stage in which animal models and proof-of-concept studies are translated into ...

At CES 2025, Earable Neuroscience introduces FRENZ Brainband's Brainwaves Research platform for pharmas and universities collaborations. Kieu My Doan Earable Inc +1 310-686-8168 email us here Visit us ...

As the CEO of UME Tech, Osokina’s forward-thinking innovations have empowered businesses to grow and achieve their goals.

Mytos’ technology will automate the manufacturing of neuronal precursors for Aspen's autologous cell therapy for the brain disorder.